House dust mite sublingual immunotherapy is safe in patients with mild-to-moderate, persistent asthma: a clinical trial

标题
House dust mite sublingual immunotherapy is safe in patients with mild-to-moderate, persistent asthma: a clinical trial
作者
关键词
-
出版物
ALLERGY
Volume 71, Issue 2, Pages 249-257
出版商
Wiley
发表日期
2015-10-14
DOI
10.1111/all.12791

向作者/读者发起求助以获取更多资源

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started